279 related articles for article (PubMed ID: 35072301)
1. Automatic detection of neuromelanin and iron in the midbrain nuclei using a magnetic resonance imaging-based brain template.
Jin Z; Wang Y; Jokar M; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Zhang Y; Min J; Liu F; He N; Yan F; Haacke EM
Hum Brain Mapp; 2022 Apr; 43(6):2011-2025. PubMed ID: 35072301
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
[TBL] [Abstract][Full Text] [Related]
3. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
[TBL] [Abstract][Full Text] [Related]
4. PENCIL imaging: A novel approach for neuromelanin sensitive MRI in Parkinson's disease.
Liu P; Wang X; Zhang Y; Huang P; Jin Z; Cheng Z; Chen Y; Xu Q; Ghassaban K; Liu Y; Chen S; He N; Yan F; Haacke EM
Neuroimage; 2024 May; 291():120588. PubMed ID: 38537765
[TBL] [Abstract][Full Text] [Related]
5. Optimizing neuromelanin contrast in the substantia nigra and locus coeruleus using a magnetization transfer contrast prepared 3D gradient recalled echo sequence.
Liu Y; Li J; He N; Chen Y; Jin Z; Yan F; Haacke EM
Neuroimage; 2020 Sep; 218():116935. PubMed ID: 32413460
[TBL] [Abstract][Full Text] [Related]
6. Application of Neuromelanin MR Imaging in Parkinson Disease.
He N; Chen Y; LeWitt PA; Yan F; Haacke EM
J Magn Reson Imaging; 2023 Feb; 57(2):337-352. PubMed ID: 36017746
[TBL] [Abstract][Full Text] [Related]
7. Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra.
Liu XL; Yang LQ; Liu FT; Wu PY; Zhang Y; Zhuang H; Shi YH; Wang J; Geng DY; Li YX
BMC Neurol; 2020 Jun; 20(1):262. PubMed ID: 32605601
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.
Langley J; Huddleston DE; Sedlacik J; Boelmans K; Hu XP
Mov Disord; 2017 Mar; 32(3):441-449. PubMed ID: 28004859
[TBL] [Abstract][Full Text] [Related]
9. Regional age-related changes of neuromelanin and iron in the substantia nigra based on neuromelanin accumulation and iron deposition.
Chen Y; Gong T; Sun C; Yang A; Gao F; Chen T; Chen W; Wang G
Eur Radiol; 2023 May; 33(5):3704-3714. PubMed ID: 36680605
[TBL] [Abstract][Full Text] [Related]
10. Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.
He N; Langley J; Huddleston DE; Chen S; Huang P; Ling H; Yan F; Hu X
Neuroimage Clin; 2020; 28():102391. PubMed ID: 32889398
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging evaluation of nigrosome 1 and neuromelanin can assist Parkinson's disease diagnosis, but requires an expert neuroradiologist.
De Pietro Franco Zorzenon C; Almeida Antônio Bienes GH; Duarte Alves E; Tobaru Tibana LA; Carrete Júnior H; Ballalai Ferraz H
Parkinsonism Relat Disord; 2021 Feb; 83():8-12. PubMed ID: 33418131
[TBL] [Abstract][Full Text] [Related]
13. Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.
Alushaj E; Handfield-Jones N; Kuurstra A; Morava A; Menon RS; Owen AM; Sharma M; Khan AR; MacDonald PA
Neuroimage Clin; 2024; 41():103577. PubMed ID: 38377722
[TBL] [Abstract][Full Text] [Related]
14. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
Taniguchi D; Hatano T; Kamagata K; Okuzumi A; Oji Y; Mori A; Hori M; Aoki S; Hattori N
Mov Disord; 2018 Sep; 33(9):1488-1492. PubMed ID: 29756366
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.
Chen X; Huddleston DE; Langley J; Ahn S; Barnum CJ; Factor SA; Levey AI; Hu X
Magn Reson Imaging; 2014 Dec; 32(10):1301-6. PubMed ID: 25086330
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
[TBL] [Abstract][Full Text] [Related]
17. Seed point discontinuity-based segmentation method for the substantia nigra and the red nucleus in quantitative susceptibility maps.
Guo T; Song Y; Li J; Fan M; Yan X; He A; Huang D; Shen C; Zhang G; Yang G
J Magn Reson Imaging; 2018 Oct; 48(4):1112-1119. PubMed ID: 29603826
[TBL] [Abstract][Full Text] [Related]
18. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
[TBL] [Abstract][Full Text] [Related]
20. Quantitative susceptibility mapping of the midbrain in Parkinson's disease.
Du G; Liu T; Lewis MM; Kong L; Wang Y; Connor J; Mailman RB; Huang X
Mov Disord; 2016 Mar; 31(3):317-24. PubMed ID: 26362242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
